A Trial of Pyridoxamine to Lower Urine Oxalate in Subjects With Stone Disease or Hyperoxaluria
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To determine whether pyridoxamine can decrease oxalate excretion in subjects who have normal
oxalate excretion (but who have had kidney stones), and in subjects who have primary
hyperoxaluria.
Phase:
Phase 2
Details
Lead Sponsor:
University of Kansas Medical Center
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)